These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21996312)

  • 1. Oculocutaneous albinism type 3: a Japanese girl with novel mutations in TYRP1 gene.
    Yamada M; Sakai K; Hayashi M; Hozumi Y; Abe Y; Kawaguchi M; Ihn H; Suzuki T
    J Dermatol Sci; 2011 Dec; 64(3):217-22. PubMed ID: 21996312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oculocutaneous albinism type 3 (OCA3): analysis of two novel mutations in TYRP1 gene in two Chinese patients.
    Zhang KH; Li Z; Lei J; Pang T; Xu B; Jiang WY; Li HY
    Cell Biochem Biophys; 2011 Dec; 61(3):523-9. PubMed ID: 21739261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins.
    Toyofuku K; Wada I; Valencia JC; Kushimoto T; Ferrans VJ; Hearing VJ
    FASEB J; 2001 Oct; 15(12):2149-61. PubMed ID: 11641241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrp1 Mutant Variants Associated with OCA3: Computational Characterization of Protein Stability and Ligand Binding.
    Patel MH; Dolinska MB; Sergeev YV
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oculocutaneous albinism with TYRP1 gene mutations in a Caucasian patient.
    Rooryck C; Roudaut C; Robine E; Müsebeck J; Arveiler B
    Pigment Cell Res; 2006 Jun; 19(3):239-42. PubMed ID: 16704458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
    Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ
    J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of oculocutaneous albinism: a compact review.
    Kamaraj B; Purohit R
    Biomed Res Int; 2014; 2014():905472. PubMed ID: 25093188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrp1 and oculocutaneous albinism type 3.
    Sarangarajan R; Boissy RE
    Pigment Cell Res; 2001 Dec; 14(6):437-44. PubMed ID: 11775055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico screening and molecular dynamics simulation of disease-associated nsSNP in TYRP1 gene and its structural consequences in OCA3.
    Kamaraj B; Purohit R
    Biomed Res Int; 2013; 2013():697051. PubMed ID: 23862152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oculocutaneous albinism (OCA) in Japanese patients: five novel mutations.
    Okamura K; Yoshizawa J; Abe Y; Hanaoka K; Higashi N; Togawa Y; Nakagawa S; Kambe N; Funasaka Y; Ohko K; Hozumi Y; Suzuki T
    J Dermatol Sci; 2014 May; 74(2):173-4. PubMed ID: 24461674
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro characterization of the intramelanosomal domain of human recombinant TYRP1 and its oculocutaneous albinism type 3-related mutant variants.
    Dolinska MB; Anderson DE; Sergeev YV
    Protein Sci; 2023 Jan; 32(1):e4518. PubMed ID: 36412553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal Efficacy of Nitisinone Treatment in a Novel Mouse Model of Oculocutaneous Albinism, Type 3.
    Onojafe IF; Megan LH; Melch MG; Aderemi JO; Alur RP; Abu-Asab MS; Chan CC; Bernardini IM; Albert JS; Cogliati T; Adams DR; Brooks BP
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):4945-4952. PubMed ID: 30347088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biallelic mutations in L-dopachrome tautomerase (DCT) cause infantile nystagmus and oculocutaneous albinism.
    Volk AE; Hedergott A; Preising M; Rading S; Fricke J; Herkenrath P; Nürnberg P; Altmüller J; von Ameln S; Lorenz B; Neugebauer A; Karsak M; Kubisch C
    Hum Genet; 2021 Aug; 140(8):1157-1168. PubMed ID: 33959807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism.
    Wang Y; Wang Z; Chen M; Fan N; Yang J; Liu L; Wang Y; Liu X
    PLoS One; 2015; 10(4):e0125651. PubMed ID: 25919014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of the molecular basis of oculocutaneous albinism in Indian patients lacking a mutation in the tyrosinase gene.
    Sengupta M; Mondal M; Jaiswal P; Sinha S; Chaki M; Samanta S; Ray K
    Br J Dermatol; 2010 Sep; 163(3):487-94. PubMed ID: 20426782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene.
    Manga P; Kromberg JG; Box NF; Sturm RA; Jenkins T; Ramsay M
    Am J Hum Genet; 1997 Nov; 61(5):1095-101. PubMed ID: 9345097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oculocutaneous albinism type IV: A boy of Moroccan descent with a novel mutation in SLC45A2.
    Konno T; Abe Y; Kawaguchi M; Storm K; Biervliet M; Courtens W; Kono M; Tomita Y; Suzuki T
    Am J Med Genet A; 2009 Aug; 149A(8):1773-6. PubMed ID: 19610114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational Analysis of TYR, OCA2, SLC45A2, and TYRP1 Genes Identifies Novel and Reported Mutations in Chinese Families with Oculocutaneous Albinism.
    Xu B; Chen X; Li H
    Altern Ther Health Med; 2023 Oct; 29(7):278-283. PubMed ID: 37471664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".
    Boissy RE; Zhao H; Oetting WS; Austin LM; Wildenberg SC; Boissy YL; Zhao Y; Sturm RA; Hearing VJ; King RA; Nordlund JJ
    Am J Hum Genet; 1996 Jun; 58(6):1145-56. PubMed ID: 8651291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.
    Toyofuku K; Valencia JC; Kushimoto T; Costin GE; Virador VM; Vieira WD; Ferrans VJ; Hearing VJ
    Pigment Cell Res; 2002 Jun; 15(3):217-24. PubMed ID: 12028586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.